Electrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic review

References

• Orlowski S, Belehradek J, Jr., Paoletti C, et al. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol. 1988;37(24):4727–4733.
   PubMed Web of Science ®Google Scholar
• Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs. 1998;9(4):319–325.
   PubMed Web of Science ®Google Scholar
• Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev. 2003;29(5):371–387.
   PubMed Web of Science ®Google Scholar
• Mir LM, Gehl J, Sersa G, et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systematically or locally and electric pulses delivered by the cliniporator by means of invasive or non-invasive electrodes. Eur J Cancer. 2006;4(11):14–15.
   Web of Science ®Google Scholar
• Marty M, Sersa G, Garbay JR, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE. Euro Standard Opera Proced Electrochemother. 2006;4(11):3–13.
   Google Scholar
• NICE NIfHaCE. Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma; 2013. 1–7.
   Google Scholar
• NICE NifHaCE. Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma. 2014. 1–8.
   Google Scholar
• Bertino G, Sersa G, De Terlizzi F, et al. European research on electrochemotherapy in head and neck cancer (EURECA) project: results of the treatment of skin cancer. Eur J Cancer. 2016;63:41–52.
   PubMed Web of Science ®Google Scholar
• Gehl J, Sersa G, Matthiessen LW, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol. 2018;57(7):874–882.
   PubMed Web of Science ®Google Scholar
• Bath-Hextall F, Nalubega S, Evans C. The needs and experiences of patients with skin cancer: a qualitative systematic review with metasynthesis. Br J Dermatol. 2017;177(3):666–687.
   PubMed Web of Science ®Google Scholar
• Buchhold B, Arnold A, Lutze S, et al. Psychosocial distress and desire for support among inpatients with skin cancer. J Dtsch Dermatol Ges. 2017;15(8):791–799.
   Web of Science ®Google Scholar
• Jaroszeski MJ, Dang V, Pottinger C, et al. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs. 2000;11(3):201–208.
   PubMed Web of Science ®Google Scholar
• Clover AJP, de Terlizzi F, Bertino G, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European international network for sharing practice in electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer. 2020;138:30–40.
   PubMed Web of Science ®Google Scholar
• Belehradek M, Domenge C, Luboinski B, et al. Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer. 1993;72(12):3694–3700.
   PubMed Web of Science ®Google Scholar
• Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977;87(3):293–298.
   PubMed Web of Science ®Google Scholar
• Groselj A, Bosnjak M, Krzan M, et al. Bleomycin concentration in patients’ plasma and tumors after electrochemotherapy. A study from InspECT group. Pharmaceutics. 2021;13(9):1324.
   PubMed Web of Science ®Google Scholar
• Jamsek C, Sersa G, Bosnjak M, et al. Long term response of electrochemotherapy with reduced dose of bleomycin in elderly patients with head and neck non-melanoma skin cancer. Radiol Oncol. 2020;54(1):79–85.
   PubMed Web of Science ®Google Scholar
• Sersa G, Mascherini M, Di Prata C, et al. Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: a matched cohort analysis from the InspECT registry. Eur J Surg Oncol. 2021;47(4):902–912.
   PubMed Web of Science ®Google Scholar
• Groselj A, Bosnjak M, Strojan P, et al. Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: preliminary results. Head Neck. 2018;40(1):120–125.
   PubMed Web of Science ®Google Scholar
• Spratt DE, Gordon Spratt EA, Wu S, et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol. 2014;32(28):3144–3155.
   PubMed Web of Science ®Google Scholar
• Dossett LA, Ben-Shabat I, Olofsson Bagge R, et al. Clinical response and regional toxicity following isolated limb infusion compared with isolated limb perfusion for in-Transit melanoma. Ann Surg Oncol. 2016;23(7):2330–2335.
   PubMed Web of Science ®Google Scholar
• Carr MJ, Sun J, DePalo D, et al. Talimogene laherparepvec (T-VEC) for the treatment of advanced locoregional melanoma after failure of immunotherapy: an international multi-institutional experience. Ann Surg Oncol. 2022;29(2):791–801.
   PubMed Web of Science ®Google Scholar
• Flaherty KT, Infante JR, Daud A, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367(18):1694–1703.
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361(12):1164–1172.
   PubMed Web of Science ®Google Scholar
• Larkin J, Hodi FS, Wolchok JD. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373(13):1270–1271.
   PubMed Web of Science ®Google Scholar
• Mir LM, Glass LF, Sersa G, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer. 1998;77(12):2336–2342.
   PubMed Web of Science ®Google Scholar
• Sersa G, Cufer T, Cemazar M, et al. Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: case report and literature review. Tumori. 2000;86(2):163–165.
   PubMed Web of Science ®Google Scholar
• Domenge C, Orlowski S, Luboinski B, et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer. 1996;77(5):956–963.
   PubMed Web of Science ®Google Scholar
• Rotunno R, Campana LG, Quaglino P, et al. Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the international network for sharing practices of electrochemotherapy registry. J Eur Acad Dermatol Venereol. 2018;32(7):1147–1154.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
   PubMed Web of Science ®Google Scholar
• Rols MP, Bachaud JM, Giraud P, et al. Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res. 2000;10(5):468–474.
   PubMed Web of Science ®Google Scholar
• Larkin JO, Collins CG, Aarons S, et al. Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg. 2007;245(3):469–479.
   PubMed Web of Science ®Google Scholar
• Quaglino P, Mortera C, Osella-Abate S, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol. 2008;15(8):2215–2222.
   PubMed Web of Science ®Google Scholar
• Campana LG, Mocellin S, Basso M, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol. 2009;16(1):191–199.
   PubMed Web of Science ®Google Scholar
• Kis E, Olah J, Ocsai H, et al. Electrochemotherapy of cutaneous metastases of melanoma–a case series study and systematic review of the evidence. Dermatol Surg. 2011;37(6):816–824.
   PubMed Web of Science ®Google Scholar
• Matthiessen LW, Chalmers RL, Sainsbury DC, et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol. 2011;50(5):621–629.
   PubMed Web of Science ®Google Scholar
• Skarlatos I, Kyrgias G, Mosa E, et al. Electrochemotherapy in cancer patients: first clinical trial in Greece. In Vivo. 2011;25(2):265–274.
   PubMed Web of Science ®Google Scholar
• Matthiessen LW, Johannesen HH, Hendel HW, et al. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol. 2012;51(6):713–721.
   PubMed Web of Science ®Google Scholar
• Curatolo P, Quaglino P, Marenco F, et al. Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. Ann Surg Oncol. 2012;19(1):192–198.
   PubMed Web of Science ®Google Scholar
• Latini A, Bonadies A, Trento E, et al. Effective treatment of Kaposi’s sarcoma by electrochemotherapy and intravenous bleomycin administration. Dermatol Ther. 2012;25(2):214–218.
   PubMed Web of Science ®Google Scholar
• Campana LG, Valpione S, Mocellin S, et al. Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg. 2012;99(6):821–830.
   PubMed Web of Science ®Google Scholar
• Campana LG, Valpione S, Falci C, et al. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat. 2012;134(3):1169–1178.
   PubMed Web of Science ®Google Scholar
• Benevento R, Santoriello A, Perna G, et al. Electrochemotherapy of cutaneous metastastes from breast cancer in elderly patients: a preliminary report. BMC Surg. 2012;12(Suppl 1):S6.
   PubMed Web of Science ®Google Scholar
• Gargiulo M, Papa A, Capasso P, et al. Electrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patients. Ann Surg. 2012;255(6):1158–1164.
   PubMed Web of Science ®Google Scholar
• Caraco C, Mozzillo N, Marone U, et al. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis. BMC Cancer. 2013;1;13:564.
   Web of Science ®Google Scholar
• Di Monta G, Caraco C, Benedetto L, et al. Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi’s sarcoma. Eur J Surg Oncol. 2014;40(1):61–66.
   PubMed Web of Science ®Google Scholar
• Campana LG, Bianchi G, Mocellin S, et al. Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: results of a non-comparative phase II study. World J Surg. 2014;38(4):813–822.
   PubMed Web of Science ®Google Scholar
• Campana LG, Galuppo S, Valpione S, et al. Bleomycin electrochemotherapy in elderly metastatic breast cancer patients: clinical outcome and management considerations. J Cancer Res Clin Oncol. 2014;140(9):1557–1565.
   PubMed Web of Science ®Google Scholar
• Campana LG, Mali B, Sersa G, et al. Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated cases. Br J Oral Maxillofac Surg. 2014;52(10):957–964.
   PubMed Web of Science ®Google Scholar
• Solari N, Spagnolo F, Ponte E, et al. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent. J Surg Oncol. 2014;109(3):270–274.
   PubMed Web of Science ®Google Scholar
• Ricotti F, Giuliodori K, Cataldi I, et al. Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases. Dermatol Ther. 2014;27(3):148–152.
   PubMed Web of Science ®Google Scholar
• Cabula C, Campana LG, Grilz G, et al. Electrochemotherapy in the treatment of cutaneous metastases from breast cancer: a multicenter cohort analysis. Ann Surg Oncol. 2015;22(S3):442–450.
   Web of Science ®Google Scholar
• Kreuter A, van Eijk T, Lehmann P, et al. Electrochemotherapy in advanced skin tumors and cutaneous metastases – a retrospective multicenter analysis. J Dtsch Dermatol Ges. 2015;13(4):308–315.
   PubMed Web of Science ®Google Scholar
• Mir-Bonafe JM, Vilalta A, Alarcon I, et al. Electrochemotherapy in the treatment of melanoma skin metastases: a report on 31 cases. Actas Dermosifiliogr. 2015;106(4):285–291.
   PubMed Web of Science ®Google Scholar
• Quaglino P, Matthiessen LW, Curatolo P, et al. Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncol. 2015;54(3):298–306.
   PubMed Web of Science ®Google Scholar
• Campana LG, Testori A, Curatolo P, et al. Treatment efficacy with electrochemotherapy: a multi-institutional prospective observational study on 376 patients with superficial tumors. Eur J Surg Oncol. 2016;42(12):1914–1923.
   PubMed Web of Science ®Google Scholar
• Guida M, Campana LG, Curatolo P, et al. Local treatment with electrochemotherapy of superficial angiosarcomas: efficacy and safety results from a multi-institutional retrospective study. J Surg Oncol. 2016;114(2):246–253.
   PubMed Web of Science ®Google Scholar
• Groselj A, Krzan M, Kosjek T, et al. Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy. Cancer Chemother Pharmacol. 2016 May;77(5):939–947.
   PubMed Web of Science ®Google Scholar
• Bourke M, Soden D, Clover AJP. Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control. Breast Cancer Res Treat. 2017;163(2):403–405.
   PubMed Web of Science ®Google Scholar
• Di Monta G, Caraco C, Simeone E, et al. Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis. J Transl Med. 2017;15(1):82.
   PubMed Web of Science ®Google Scholar
• Campana LG, Marconato R, Valpione S, et al. Basal cell carcinoma: 10-year experience with electrochemotherapy. J Transl Med. 2017;15(1):122.
   PubMed Web of Science ®Google Scholar
• Kunte C, Letule V, Gehl J, et al. Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. Br J Dermatol. 2017;176(6):1475–1485.
   PubMed Web of Science ®Google Scholar
• Matthiessen LW, Keshtgar M, Curatolo P, et al. Electrochemotherapy for breast cancer-results from the INSPECT database. Clin Breast Cancer. 2018;18(5):e909–e917.
   PubMed Web of Science ®Google Scholar
• Gargiulo M, Serra Mestre JM, Cortese A, et al. Long term effectiveness of electrochemotherapy for the treatment of lower lip squamous cell carcinoma. J Craniomaxillofac Surg. 2018;46(11):1968–1974.
   PubMed Web of Science ®Google Scholar
• Al-Hadithy N, Dehnel A, George A, et al. Patient reported outcomes in prospective cohort study of electrochemotherapy. Int J Surg. 2018;52:110–119.
   PubMed Web of Science ®Google Scholar
• Wichtowski M, Murawa D, Czarnecki R, et al. Electrochemotherapy in the treatment of breast cancer metastasis to the skin and subcutaneous Tissue – Multicenter experience. Oncol Res Treat. 2019;42(1–2):47–51.
   PubMed Web of Science ®Google Scholar
• Bonadies A, Bertozzi E, Cristiani R, et al. Electrochemotherapy in skin malignancies of head and neck cancer patients: clinical efficacy and aesthetic benefits. Acta Derm Venereol. 2019;99(13):1246–1252.
   PubMed Web of Science ®Google Scholar
• Kis EG, Baltas E, Ocsai H, et al. Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas. Sci Rep. 2019;9(1):4285.
   PubMed Web of Science ®Google Scholar
• Longo F, Perri F, Pavone E, et al. Electrochemotherapy as palliative treatment in patients with advanced head and neck tumours: outcome analysis in 93 patients treated in a single institution. Oral Oncol. 2019;92:77–84.
   PubMed Web of Science ®Google Scholar
• Campana LG, Kis E, Bottyan K, et al. Electrochemotherapy for advanced cutaneous angiosarcoma: a European register-based cohort study from the international network for sharing practices of electrochemotherapy (InspECT). Int J Surg. 2019;72:34–42.
   PubMed Web of Science ®Google Scholar
• Pirc E, Federici C, Bosnjak M, et al. Early cost-effectiveness analysis of electrochemotherapy as a prospect treatment modality for skin melanoma. Clin Ther. 2020;42(8):1535–1548 e2.
   PubMed Web of Science ®Google Scholar
• Fabrizio T, Cagiano L, De Terlizzi F, et al. Neoadjuvant treatment by ECT in cutaneous malignant neoplastic lesions. J Plast Reconstr Aesthet Surg. 2020;73(5):904–912.
   PubMed Web of Science ®Google Scholar
• Borgognoni L, Pescitelli L, Gerlini G, et al. Efficacy of electrochemotherapy in the treatment of cutaneous melanoma metastases and rare non-melanoma skin cancer. Anticancer Res. 2020;40(11):6485–6492.
   PubMed Web of Science ®Google Scholar
• Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 1996;77(5):964–971.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247.
   PubMed Web of Science ®Google Scholar
• Rudolf ZS, Cemazar B, Miklavcic M, et al. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol Oncol. 1995;29:229–235.
   Google Scholar
• Mali B, Jarm T, Snoj M, et al. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol. 2013;39(1):4–16.
   PubMed Web of Science ®Google Scholar
• Limper AH. Chemotherapy-induced lung disease. Clin Chest Med. 2004;25(1):53–64.
   PubMed Web of Science ®Google Scholar
• Martin WG, Ristow KM, Habermann TM, et al. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin’s lymphoma. J Clin Oncol. 2005;23(30):7614–7620. Oct 20
   PubMed Web of Science ®Google Scholar
• Petrelli F, Ghidini A, Simioni A, et al. Impact of electrochemotherapy in metastatic cutaneous melanoma: a contemporary systematic review and Meta-analysis. Acta Oncol. 2021;10:1–12.
   Web of Science ®Google Scholar
• Seyed Jafari SM, Jabbary Lak F, Gazdhar A, et al. Application of electrochemotherapy in the management of primary and metastatic cutaneous malignant tumours: a systematic review and meta-analysis. Eur J Dermatol. 2018;28(3):287–313.
   PubMed Web of Science ®Google Scholar
• Falk H, Matthiessen LW, Wooler G, et al. Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy. Acta Oncol. 2018;57(3):311–319.
   PubMed Web of Science ®Google Scholar
• Dolinsek T, Prosen L, Cemazar M, et al. Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors. Radiol Oncol. 2016;50(3):274–279.
   PubMed Web of Science ®Google Scholar
• Villani A, Potestio L, Fabbrocini G, et al. New emerging treatment options for advanced basal cell carcinoma and squamous cell carcinoma. Adv Ther. 2022;39(3):1164–1178.
   PubMed Web of Science ®Google Scholar
• Heppt MV, Eigentler TK, Kahler KC, et al. Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis. Cancer Immunol Immunother. 2016;65(8):951–959.
   PubMed Web of Science ®Google Scholar
• Valpione S, Campana LG, Pigozzo J, et al. Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib. Radiol Oncol. 2015;49(1):71–74.
   PubMed Web of Science ®Google Scholar
• Bastrup FA, Vissing M, Gehl J. Electrochemotherapy for metastatic cutaneous melanoma. Acta Oncol. 2022;61(5):531–532.
   PubMed Web of Science ®Google Scholar
• Vissing M, Ploen J, Pervan M, et al. Study protocol designed to investigate tumour response to calcium electroporation in cancers affecting the skin: a non-randomised phase II clinical trial. BMJ Open. 2021;11(6):e046779.
   PubMed Web of Science ®Google Scholar
• Falk Hansen H, Bourke M, Stigaard T, et al. Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study. Endosc Int Open. 2020;8(2):E124–E132.
   PubMed Web of Science ®Google Scholar
• Colombo GL, Matteo SD, Mir LM. Cost-effectiveness analysis of electrochemotherapy with the cliniporatortrade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors. Ther Clin Risk Manag. 2008;4(2):541–548.
   PubMedGoogle Scholar